# Long-Acting Reversible Contraception

> **NCT01299116** · PHASE4 · COMPLETED · sponsor: **FHI 360** · enrollment: 916 (actual)

## Conditions studied

- Contraception

## Interventions

- **DRUG:** DMPA
- **DRUG:** oral contraceptives
- **DRUG:** Implanon®
- **DRUG:** ParaGard®
- **DRUG:** Mirena®

## Key facts

- **NCT ID:** NCT01299116
- **Lead sponsor:** FHI 360
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-12
- **Primary completion:** 2016-06
- **Final completion:** 2016-12
- **Target enrollment:** 916 (ACTUAL)
- **Last updated:** 2018-02-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01299116

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01299116, "Long-Acting Reversible Contraception". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01299116. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*